{"id":11775,"date":"2023-11-09T22:15:00","date_gmt":"2023-11-09T14:15:00","guid":{"rendered":"https:\/\/flcube.com\/?p=11775"},"modified":"2025-01-06T18:15:40","modified_gmt":"2025-01-06T10:15:40","slug":"ciie-2023-danaher-boehringer-ingelheim-merck-jj-beigene-and-fosun-pharma-announce-china-partnerships","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=11775","title":{"rendered":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships"},"content":{"rendered":"\n<p>The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (<a href=\"https:\/\/www.google.com\/finance\/quote\/DHR:NYSE\">NYSE: DHR<\/a>), Boehringer-Ingelheim (BI), Merck Sharp &amp; Dohme (MSD, <a href=\"https:\/\/www.google.com\/finance\/quote\/MRK:NYSE\">NYSE: MRK<\/a>), Johnson &amp; Johnson (J&amp;J, <a href=\"https:\/\/www.google.com\/finance\/quote\/JNJ:NYSE\">NYSE: JNJ<\/a>), BeiGene (<a href=\"https:\/\/www.google.com\/finance\/quote\/BGNE:NASDAQ\">NASDAQ: BGNE<\/a>), and Fosun Pharma (<a href=\"https:\/\/www.google.com\/finance\/quote\/600196:SHA\">SHA: 600196<\/a>), all of which have revealed significant collaborations.<\/p>\n\n\n\n<p><strong>Danaher&#8217;s Western China Center<\/strong><br>Danaher has plans to jointly establish its Western China center with local firm Zein Biotechnology in Chongqing. This move is set to strengthen Danaher&#8217;s presence in the region and enhance its service capabilities in China.<\/p>\n\n\n\n<p><strong>Boehringer-Ingelheim&#8217;s Collaboration with NMI Pharmaceutical<\/strong><br>BI will provide process development and manufacturing services to Guangzhou-based NMI Pharmaceutical, particularly in relation to the latter\u2019s inflammatory drugs. This partnership is aimed at boosting the development and production of important medications in China.<\/p>\n\n\n\n<p><strong>MSD and Peking University Joint Laboratory<\/strong><br>MSD is set to establish a joint laboratory for infectious disease prevention and control technology with Peking University. The collaboration is designed to promote the integration of industry, academia, and research, and to explore long-term cooperation projects in public health technology innovation, real-world research in key disease fields, research transformation, and public health talent development.<\/p>\n\n\n\n<p><strong>Johnson &amp; Johnson&#8217;s Medical Device Procurement Deals<\/strong><br>J&amp;J has struck significant medical device procurement deals with local companies Jointown Medical Devices Group, China Resources Biopharma, and Sinopharm, with investments of USD 500 million, USD 100 million, and USD 400 million respectively. These deals cover areas such as surgery, orthopedics, and intervention solutions.<\/p>\n\n\n\n<p><strong>BeiGene and Cowell Health Cancer Management System<\/strong><br>BeiGene has joined forces with Cowell Health to establish a comprehensive cancer patient full lifecycle management system. This collaboration aims to improve cancer care and management for patients in China.<\/p>\n\n\n\n<p><strong>Fosun Pharma and Shanghai Zhangjiang Group Agreement<\/strong><br>Finally, Fosun Pharma and Shanghai Zhangjiang Group have agreed to delve deeper into innovation leadership, industrial cooperation, and talent attraction and cohesion. This partnership is set to enhance the innovation capabilities and industry collaboration in the Chinese pharmaceutical sector.- <a href=\"https:\/\/flcube.com\">Flcube.com<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The 6th China International Import Expo (CIIE) held in Shanghai this week has been a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[185,2092,30,535,20,159,150,149,120,2675,176,846,3046,1265,858,903,892],"class_list":["post-11775","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-beigene","tag-beone-medicines","tag-biotech","tag-danaher","tag-finance","tag-fosun-pharmaceutical","tag-jj","tag-johnson-johnson","tag-merck","tag-merck-sharp-dohme","tag-msd","tag-nasdaq-bgne","tag-nasdaq-onc","tag-nyse-dhr","tag-nyse-jnj","tag-nyse-mrk","tag-sha-600196"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (NYSE: DHR), Boehringer-Ingelheim (BI), Merck Sharp &amp; Dohme (MSD, NYSE: MRK), Johnson &amp; Johnson (J&amp;J, NYSE: JNJ), BeiGene (NASDAQ: BGNE), and Fosun Pharma (SHA: 600196), all of which have revealed significant collaborations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=11775\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=11775\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-09T14:15:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-06T10:15:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships\",\"datePublished\":\"2023-11-09T14:15:00+00:00\",\"dateModified\":\"2025-01-06T10:15:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775\"},\"wordCount\":361,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"BeiGene\",\"BeOne Medicines\",\"Biotech\",\"Danaher\",\"Finance\",\"Fosun Pharmaceutical\",\"J&amp;J\",\"Johnson &amp; Johnson\",\"Merck\",\"Merck Sharp &amp; Dohme\",\"MSD\",\"NASDAQ: BGNE\",\"NASDAQ: ONC\",\"NYSE: DHR\",\"NYSE: JNJ\",\"NYSE: MRK\",\"SHA: 600196\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=11775#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=11775\",\"name\":\"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-11-09T14:15:00+00:00\",\"dateModified\":\"2025-01-06T10:15:40+00:00\",\"description\":\"The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (NYSE: DHR), Boehringer-Ingelheim (BI), Merck Sharp & Dohme (MSD, NYSE: MRK), Johnson & Johnson (J&J, NYSE: JNJ), BeiGene (NASDAQ: BGNE), and Fosun Pharma (SHA: 600196), all of which have revealed significant collaborations.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=11775\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=11775#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships - Insight, China&#039;s Pharmaceutical Industry","description":"The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (NYSE: DHR), Boehringer-Ingelheim (BI), Merck Sharp & Dohme (MSD, NYSE: MRK), Johnson & Johnson (J&J, NYSE: JNJ), BeiGene (NASDAQ: BGNE), and Fosun Pharma (SHA: 600196), all of which have revealed significant collaborations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=11775","og_locale":"en_US","og_type":"article","og_title":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=11775","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-11-09T14:15:00+00:00","article_modified_time":"2025-01-06T10:15:40+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=11775#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=11775"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships","datePublished":"2023-11-09T14:15:00+00:00","dateModified":"2025-01-06T10:15:40+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=11775"},"wordCount":361,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["BeiGene","BeOne Medicines","Biotech","Danaher","Finance","Fosun Pharmaceutical","J&amp;J","Johnson &amp; Johnson","Merck","Merck Sharp &amp; Dohme","MSD","NASDAQ: BGNE","NASDAQ: ONC","NYSE: DHR","NYSE: JNJ","NYSE: MRK","SHA: 600196"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=11775#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=11775","url":"https:\/\/flcube.com\/?p=11775","name":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-11-09T14:15:00+00:00","dateModified":"2025-01-06T10:15:40+00:00","description":"The 6th China International Import Expo (CIIE) held in Shanghai this week has been a platform for multiple companies to announce their strategic partnerships in China. Among the notable participants are Danaher (NYSE: DHR), Boehringer-Ingelheim (BI), Merck Sharp & Dohme (MSD, NYSE: MRK), Johnson & Johnson (J&J, NYSE: JNJ), BeiGene (NASDAQ: BGNE), and Fosun Pharma (SHA: 600196), all of which have revealed significant collaborations.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=11775#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=11775"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=11775#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&amp;J, BeiGene, and Fosun Pharma Announce China Partnerships"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11775"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11775\/revisions"}],"predecessor-version":[{"id":11776,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/11775\/revisions\/11776"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}